Higher expression of the heterogeneous nuclear ribonucleoprotein K in melanoma

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2619-2627

  Wen, Fushi ^a   Shen, Alex ^a   Shanas, Reneé ^a   Bhattacharyya, Achyut ^a   Lian, Fangru ^a   Hostetter, Galen ^b   Shi, Jiaqi ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR 4E; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; MYC PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CARCINOGENESIS; CELL FRACTIONATION; CELL FUNCTION; COLONY FORMATION; CONTROLLED STUDY; DYSPLASTIC NEVUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; ONCOGENE C MYC; ONCOGENE SRC; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE CULTURE; TISSUE MICROARRAY; TUMOR GROWTH; WESTERN BLOTTING;

BLOTTING, WESTERN; CYTOPLASM; DYSPLASTIC NEVUS SYNDROME; EUKARYOTIC INITIATION FACTOR-4E; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOCYTES; MELANOMA; PHOSPHORYLATION; PROGNOSIS; RNA, SMALL INTERFERING; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 78049486731     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1121-1     Document Type: Article

References (35)

1. K Bomsztyk O Denisenko J Ostrowski 2004 hnRNP K: one protein multiple processes Bioessays 26 629 638 1:CAS:528:DC%2BD2cXltlGjtb0%3D 10.1002/bies.20048 15170860
2. K Klimek-Tomczak LS Wyrwicz S Jain K Bomsztyk J Ostrowski 2004 Characterization of hnRNP K protein-RNA interactions J Mol Biol 342 1131 1141 1:CAS:528:DC%2BD2cXntlOgsbc%3D 10.1016/j.jmb.2004.07.099 15351640
3. M Mikula A Dzwonek J Karczmarski T Rubel M Dadlez LS Wyrwicz, et al. 2006 Landscape of the hnRNP K protein-protein interactome Proteomics 6 2395 2406 1:CAS:528:DC%2BD28XkslCgsL0%3D 10.1002/pmic.200500632 16518874
4. M Lynch L Chen MJ Ravitz S Mehtani K Korenblat MJ Pazin, et al. 2005 hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation Mol Cell Biol 25 6436 6453 1:CAS:528: DC%2BD2MXntVShurw%3D 10.1128/MCB.25.15.6436-6453.2005 16024782
5. JL Baber D Libutti D Levens N Tjandra 1999 High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor J Mol Biol 289 949 962 1:CAS:528: DyaK1MXjslKht74%3D 10.1006/jmbi.1999.2818 10369774
6. M Takimoto T Tomonaga M Matunis M Avigan H Krutzsch G Dreyfuss, et al. 1993 Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro J Biol Chem 268 18249 18258 1:CAS:528:DyaK3sXlslGgsLo%3D 8349701
7. EF Michelotti GA Michelotti AI Aronsohn D Levens 1996 Heterogeneous nuclear ribonucleoprotein K is a transcription factor Mol Cell Biol 16 2350 2360 1:CAS:528:DyaK28XisFekt70%3D 8628302
8. SA Ritchie MK Pasha DJ Batten RK Sharma DJ Olson AR Ross, et al. 2003 Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription Nucleic Acids Res 31 1502 1513 1:CAS:528:DC%2BD3sXit1yksrc%3D 10.1093/nar/gkg246 12595559
9. A Moumen P Masterson MJ O'Connor SP Jackson 2005 hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage Cell 123 1065 1078 1:CAS:528:DC%2BD28XptVOl 10.1016/j.cell.2005.09.032 16360036
10. H Habelhah K Shah L Huang A Ostareck-Lederer AL Burlingame KM Shokat, et al. 2001 ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation Nat Cell Biol 3 325 330 1:CAS:528: DC%2BD3MXitFemtrc%3D 10.1038/35060131 11231586
11. K Nagano JR Masters A Akpan A Yang S Corless C Wood, et al. 2004 Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons Oncogene 23 1693 1703 1:CAS:528:DC%2BD2cXhslGisLY%3D 10.1038/sj.onc.1207297 14647428
12. K Klimek-Tomczak M Mikula A Dzwonek A Paziewska J Karczmarski E Hennig, et al. 2006 Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa Br J Cancer 94 586 592 1:CAS:528:DC%2BD28Xhs1ersr8%3D 10.1038/sj.bjc.6602938 16404425
13. J Ostrowski K Bomsztyk 2003 Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation Br J Cancer 89 1493 1501 1:CAS:528:DC%2BD3sXotFeksL4%3D 10.1038/sj.bjc.6601250 14562022
14. H Hatakeyama T Kondo K Fujii Y Nakanishi H Kato S Fukuda, et al. 2006 Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer Proteomics 6 6300 6316 1:CAS:528:DC%2BD2sXhsFGmt74%3D 10.1002/pmic.200600488 17133371
15. M Mandal R Vadlamudi D Nguyen RA Wang L Costa R Bagheri-Yarmand, et al. 2001 Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function J Biol Chem 276 9699 9704 1:CAS:528:DC%2BD3MXis1Olur8%3D 10.1074/jbc.M008514200 11121407
16. D Perrotti P Neviani 2007 From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way Clin Cancer Res 13 1638 1642 1:CAS:528:DC%2BD2sXivV2gtrw%3D 10.1158/1078-0432.CCR-06-2320 17363515
17. R Zhou R Shanas MA Nelson A Bhattacharyya J Shi 2009 Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 Int J Cancer 126 395 404 10.1002/ijc.24744
18. B Carpenter M McKay SR Dundas LC Lawrie C Telfer GI Murray 2006 Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer Br J Cancer 95 921 927 1:CAS:528:DC%2BD28XhtVans7nI 10.1038/sj.bjc.6603349 16953238
19. PB Gupta C Kuperwasser JP Brunet S Ramaswamy WL Kuo JW Gray, et al. 2005 The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nat Genet 37 1047 1054 1:CAS:528:DC%2BD2MXhtVCntL7K 10.1038/ng1634 16142232
20. A Doldan A Chandramouli R Shanas A Bhattacharyya JT Cunningham MA Nelson, et al. 2008 Loss of the eukaryotic initiation factor 3f in pancreatic cancer Mol Carcinog 47 235 244 1:CAS:528:DC%2BD1cXjslCitL4%3D 10.1002/mc.20379 17918192
21. SR Dundas LC Lawrie PH Rooney GI Murray 2005 Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival J Pathol 205 74 81 1:CAS:528:DC%2BD2MXotFyqsQ%3D%3D 10.1002/path.1672 15532096
22. J Shi JW Hershey MA Nelson 2009 Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis FEBS Lett 583 971 977 1:CAS:528:DC%2BD1MXjt1Kmurs%3D 10.1016/j.febslet.2009.02.028 19245811
23. J Shi A Kahle JW Hershey BM Honchak JA Warneke SP Leong, et al. 2006 Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells Oncogene 25 4923 4936 1:CAS:528: DC%2BD28XnvVyltr0%3D 10.1038/sj.onc.1209495 16532022
24. J Shi Y Feng AC Goulet RR Vaillancourt NA Sachs JW Hershey, et al. 2003 The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis J Biol Chem 278 5062 5071 1:CAS:528:DC%2BD3sXhtVKlt7w%3D 10.1074/jbc.M206427200 12446680
25. R Zhou R Shanas MA Nelson A Bhattacharyya J Shi 2010 Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 Int J Cancer 126 395 404 1:CAS:528: DC%2BD1MXhsFGjsrvN 10.1002/ijc.24744 19609950
26. I Pino R Pio G Toledo N Zabalegui S Vicent N Rey, et al. 2003 Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer Lung Cancer 41 131 143 10.1016/S0169-5002(03) 00193-4 12871776
27. BC Blaxall LD Dwyer-Nield AK Bauer TJ Bohlmeyer AM Malkinson JD Port 2000 Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue Mol Carcinog 28 76 83 1:CAS:528:DC%2BD3cXkslagurg%3D 10.1002/1098- 2744(200006)28:2<76::AID-MC3>3.0.CO;2-0 10900464
28. J Ostrowski Y Kawata DS Schullery ON Denisenko K Bomsztyk 2003 Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci Nucleic Acids Res 31 3954 3962 1:CAS:528:DC%2BD3sXltl2ktrw%3D 10.1093/nar/gkg452 12853611
29. LH Miau CJ Chang BJ Shen WH Tsai SC Lee 1998 Identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a repressor of C/EBPbeta-mediated gene activation J Biol Chem 273 10784 10791 1:CAS:528:DyaK1cXivFKms78%3D 10.1074/jbc.273.17.10784 9553145
30. JR Evans SA Mitchell KA Spriggs J Ostrowski K Bomsztyk D Ostarek, et al. 2003 Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo Oncogene 22 8012 8020 10.1038/sj.onc.1206645 12970749
31. M Notari P Neviani R Santhanam BW Blaser JS Chang A Galietta, et al. 2006 A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation Blood 107 2507 2516 1:CAS:528:DC%2BD28XisFOju7w%3D 10.1182/blood-2005-09-3732 16293596
32. HS Choi CK Hwang KY Song PY Law LN Wei HH Loh 2009 Poly(C)-binding proteins as transcriptional regulators of gene expression Biochem Biophys Res Commun 380 431 436 1:CAS:528:DC%2BD1MXis1GktLk%3D 10.1016/j.bbrc.2009.01.136 19284986
33. G Jonsson PO Bendahl T Sandberg A Kurbasic J Staaf L Sunde, et al. 2005 Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32 J Natl Cancer Inst 97 1377 1382 10.1093/jnci/dji280 16174859
34. P Ghosh L Chin 2009 Genetics and genomics of melanoma Expert Rev Dermatol 4 131 143 1:CAS:528:DC%2BD1MXjvV2ntrc%3D 10.1586/edm.09.2 20126509
35. LA Garraway HR Widlund MA Rubin G Getz AJ Berger S Ramaswamy, et al. 2005 Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 436 117 122 1:CAS:528: DC%2BD2MXlvVGitbc%3D 10.1038/nature03664 16001072